Clinical Trial Update: Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating glycerol trierucate for adrenoleukodystrophy was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy

Drugs mentioned

• Glycerol Trierucate (glycerol trierucate)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Adrenoleukodystrophy | Phase 2 | Status: TERMINATED | Results posted: 2020-10-23